Related Experiment Video
Updated: Sep 27, 2025

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
Published on: May 6, 2019
Cancer germline antigens and tumor-agnostic CD8+ T cell evasion
Dian Kortleve1, Rui M L Coelho1, Dora Hammerl1
1Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC Cancer Institute, Dr Molewaterplein 40, 3015, GD, Rotterdam, The Netherlands.
Abstract:
Cancer germline antigens (CGAs) are expressed in immune-privileged germline tissues, while epigenetically silenced in somatic tissues. CGAs become re-expressed in tumors and can promote oncogenesis. Tumors prominently exploit mechanisms similar to those in germline tissues to shield from immunosurveillance. We hypothesize that CGAs contribute towards tumor escape from immune effector CD8+ T cells. For illustrative purposes, we assessed the co-presence or -absence of CGAs with these cells in multiple tumor types. Considering a broad array of CD8+ T cell evasive mechanisms, we exemplify the co-occurrence of gene transcripts of eight CGAs with those of adhesion molecules, endothelial cells, and/or the Wnt pathway. We present a novel concept of CGAs and their association with CD8+ T cell evasion, which may be relevant for future immunotherapeutic interventions.
Insights
Cancer germline antigens (CGAs) re-expressed in tumors may help cancer cells evade immune detection by CD8+ T cells. This study explores CGAs
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Cancer germline antigens (CGAs) are normally confined to immune-privileged germline tissues but are re-expressed in tumors, potentially promoting oncogenesis.
- Tumors utilize mechanisms similar to germline tissues to evade immune surveillance, particularly from CD8+ T cells.
- The role of CGAs in tumor immune evasion remains largely unexplored.
Purpose of the Study:
- To investigate the hypothesis that CGAs contribute to tumor escape from CD8+ T cell-mediated immunosurveillance.
- To explore the association between CGAs and known CD8+ T cell evasion mechanisms in various cancer types.
Main Methods:
- Assessed the co-expression patterns of eight cancer germline antigen transcripts with transcripts of adhesion molecules, endothelial cells, and Wnt pathway components in multiple tumor types.
- Analyzed the co-presence or co-absence of CGAs with CD8+ T cells in tumor tissues.
Main Results:
- Demonstrated the co-occurrence of gene transcripts for eight CGAs with those involved in CD8+ T cell evasion mechanisms.
- Observed associations between CGAs and factors facilitating tumor immune escape, such as adhesion molecules and the Wnt pathway.
Conclusions:
- CGAs represent a novel factor associated with CD8+ T cell evasion in tumors.
- The proposed concept of CGAs contributing to tumor immune evasion may offer new avenues for immunotherapeutic interventions.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

